Literature DB >> 25234529

American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Salvatore L Ruggiero1, Thomas B Dodson2, John Fantasia3, Reginald Goodday4, Tara Aghaloo5, Bhoomi Mehrotra6, Felice O'Ryan7.   

Abstract

Strategies for management of patients with, or at risk for, medication-related osteonecrosis of the jaw (MRONJ) were set forth in the American Association of Oral and Maxillofacial Surgeons (AAOMS) position papers in 2007 and 2009. The position papers were developed by a special committee appointed by the board and composed of clinicians with extensive experience in caring for these patients and basic science researchers. The knowledge base and experience in addressing MRONJ has expanded, necessitating modifications and refinements to the previous position paper. This special committee met in September 2013 to appraise the current literature and revise the guidelines as indicated to reflect current knowledge in this field. This update contains revisions to diagnosis, staging, and management strategies and highlights current research status. The AAOMS considers it vitally important that this information be disseminated to other relevant health care professionals and organizations.
Copyright © 2014 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25234529     DOI: 10.1016/j.joms.2014.04.031

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   2.136


  518 in total

Review 1.  Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015.

Authors:  A Khan; A Morrison; A Cheung; W Hashem; J Compston
Journal:  Osteoporos Int       Date:  2015-10-22       Impact factor: 4.507

2.  A comparative effectiveness pilot study of teriparatide for medication-related osteonecrosis of the jaw: daily versus weekly administration.

Authors:  Y Ohbayashi; A Iwasaki; F Nakai; T Mashiba; M Miyake
Journal:  Osteoporos Int       Date:  2019-11-25       Impact factor: 4.507

3.  OPG-Fc but Not Zoledronic Acid Discontinuation Reverses Osteonecrosis of the Jaws (ONJ) in Mice.

Authors:  Rafael Scaf de Molon; Hiroaki Shimamoto; Olga Bezouglaia; Flavia Q Pirih; Sarah M Dry; Paul Kostenuik; Rogely W Boyce; Denise Dwyer; Tara L Aghaloo; Sotirios Tetradis
Journal:  J Bone Miner Res       Date:  2015-05-27       Impact factor: 6.741

Review 4.  Oral rehabilitation of the cancer patient: A formidable challenge.

Authors:  Ivana Petrovic; Evan B Rosen; Evan Matros; Joseph M Huryn; Jatin P Shah
Journal:  J Surg Oncol       Date:  2018-05-03       Impact factor: 3.454

Review 5.  Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors.

Authors:  Jason T Wan; Douglas M Sheeley; Martha J Somerman; Janice S Lee
Journal:  Bone Res       Date:  2020-03-11       Impact factor: 13.567

Review 6.  Osteoporosis and Periodontitis.

Authors:  Chin-Wei Jeff Wang; Laurie K McCauley
Journal:  Curr Osteoporos Rep       Date:  2016-12       Impact factor: 5.096

7.  Effect of bisphosphonate treatment on the jawbone: an exploratory study using periapical and panoramic radiographic evaluation.

Authors:  Imad Barngkgei; Esam Halboub; Abeer Almashraqi
Journal:  Oral Radiol       Date:  2018-11-07       Impact factor: 1.852

8.  Trabecular structure designation using fractal analysis technique on panoramic radiographs of patients with bisphosphonate intake: a preliminary study.

Authors:  Kemal Özgür Demiralp; Emine Şebnem Kurşun-Çakmak; Seval Bayrak; Nihat Akbulut; Cemal Atakan; Kaan Orhan
Journal:  Oral Radiol       Date:  2018-02-15       Impact factor: 1.852

9.  Panoramic radiographic features that predict the development of bisphosphonate-related osteonecrosis of the jaw.

Authors:  Ryota Kubo; Yoshiko Ariji; Tohru Taniguchi; Michihito Nozawa; Akitoshi Katsumata; Eiichiro Ariji
Journal:  Oral Radiol       Date:  2017-06-12       Impact factor: 1.852

10.  Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review.

Authors:  Ourania Nicolatou-Galitis; Maria Kouri; Erofili Papadopoulou; Emmanouil Vardas; Dimitra Galiti; Joel B Epstein; Sharon Elad; Giuseppina Campisi; Nikolaos Tsoukalas; Kivanc Bektas-Kayhan; Winston Tan; Jean-Jacques Body; Cesar Migliorati; Rajesh V Lalla
Journal:  Support Care Cancer       Date:  2018-10-23       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.